The potential risk of AVM rupture was evaluated in the A Randomized demo of Unruptured Brain Arteriovenous malformations (ARUBA) trial. This research exposed a lowered threat of stroke and mortality in individuals managed conservatively compared to individuals who underwent interventional therapy.[thirteen]  The ARUBA trial in comparison clinical administration alone to https://www.sgvascularctr.com/service/vascular-malformations/